Jarmo Oksi
oksi@utu.fi |
Publications
- Borrelia burgdorferi specific serum and cerebrospinal fluid antibodies in Lyme neuroborreliosis (2022)
- Diagnostic Microbiology and Infectious Disease
(A1 Refereed original research article in a scientific journal) - Consumption of healthcare services and antibiotics in patients with presumed disseminated Lyme borreliosis before and after evaluation of an infectious disease specialist (2022)
- Ticks and Tick-borne Diseases
(A1 Refereed original research article in a scientific journal) - Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM—a prospective, randomized, single-centre, open-label study (2022)
- Clinical Microbiology and Infection
(A1 Refereed original research article in a scientific journal) - ‘Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM’ – Author's reply (2022)
- Clinical Microbiology and Infection
(B1 Non-refereed article in a scientific journal) - Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent Patients (2022)
- Frontiers in immunology
(A1 Refereed original research article in a scientific journal) - Low pre-vaccination SARS-CoV-2 seroprevalence in Finnish health care workers: a prospective cohort study (2022)
- Infectious Diseases
(A1 Refereed original research article in a scientific journal) - Association between Administration of IL-6 Antagonists and Mortality among Patients Hospitalized for COVID-19: A Meta-analysis (2021)
- JAMA: Journal of the American Medical Association
(A2 Refereed review article in a scientific journal ) - C6 peptide enzyme immunoassay in Lyme borreliosis serology (2021)
- Journal of Microbiological Methods
(A1 Refereed original research article in a scientific journal) - Clinical characteristics and evaluation of the incidence of cryptococcosis in Finland 2004-2018 (2021)
- Infectious Diseases
(A1 Refereed original research article in a scientific journal) - IL-6 and other biomarkers as predictors of severity in COVID-19 (2021)
- Annals of Medicine
(A1 Refereed original research article in a scientific journal)



